T1	Participants 83 144	rheumatoid arthritis patients who had no clinical improvement
T2	Participants 359 440	rheumatoid arthritis (RA) patients who have not responded clinically to treatment
T3	Participants 804 912	patients who did not show 20% improvement by American College of Rheumatology criteria (ACR20 nonresponders)
T4	Participants 2387 2424	patients without clinical improvement
